InvestorsHub Logo

powerbattles

06/01/13 3:53 AM

#524 RE: ash111 #514

It's really don't matter for NGX-1998 Phase 3 development. They going to sell all the asset and shares holders getting nothing eom

As of April 15, 2013, NeurogesX, Inc. (the “NeurogesX”) and Acorda Therapeutics, Inc. (“Acorda”) entered into an Asset Purchase Agreement (the “APA”). Pursuant to the terms of the APA, Acorda will acquire at the closing certain assets of NeurogesX (including NeurogesX’ assets relating to its product Qutenza and its product candidate NGX-1998),